These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2189903)

  • 41. Monotherapy of mild hypertension with nifedipine.
    Pacheco JP; Fan F; Wright RA; Corkadel LK; Horwitz LD; Reeves RL
    Am J Med; 1986 Dec; 81(6A):20-4. PubMed ID: 3541596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension.
    Takabatake T; Yamamoto Y; Nakamura S; Hashimoto N; Satoh S; Yamada Y; Ohta H; Hattori N
    Eur J Clin Pharmacol; 1987; 33(3):215-9. PubMed ID: 3319645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S89-93. PubMed ID: 2467138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitrendipine vs. long-acting nifedipine in mild, moderate and severe hypertension.
    Guazzi MD; De Cesare N; Galli C; Tamborini G; Salvioni A
    Angiology; 1986 Jul; 37(7):508-18. PubMed ID: 2942062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.
    Tsuchihashi T; Tsukashima A; Matsumura K; Abe I; Tominaga M; Nakao Y; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1991; 41(3):255-7. PubMed ID: 1748143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exercise performance in patients with uncomplicated essential hypertension. Effects of nifedipine-induced acute blood pressure reduction.
    Agostoni P; Doria E; Berti M; Alimento M; Tamborini G; Fiorentini C
    Chest; 1992 Jun; 101(6):1591-6. PubMed ID: 1600777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.
    Heagerty AM; Swales JD
    Br J Clin Pharmacol; 1989 Apr; 27(4):411-6. PubMed ID: 2655687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Shishido A; Noguchi H
    J Clin Pharmacol; 1987 Feb; 27(2):111-7. PubMed ID: 3680562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Kuwahara N; Shishido A; Noguchi H
    J Clin Pharmacol; 1988 Apr; 28(4):350-5. PubMed ID: 3392233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine.
    Shimamoto H; Shimamoto Y
    J Hum Hypertens; 1995 Apr; 9(4):271-9. PubMed ID: 7595910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.
    Aoki K; Sato K; Kawaguchi Y; Yamamoto M
    Eur J Clin Pharmacol; 1982; 23(3):197-201. PubMed ID: 7173292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.